Takeda Pharmaceutical Co Ltd Phathom Pharmaceuticals, Inc. (PHAT) insider trading activity

Takeda Pharmaceutical CO LTD is > 10% Shareholder of Phathom Pharmaceuticals, Inc.. Currently has a direct ownership of 3.76 Million shares of PHAT, which is worth approximately $30.7 Million. The most recent transaction as insider was on May 26, 2021, when has been sold 12,358 shares (Common Stock) at a price of $36.68 per share, resulting in proceeds of $453,291. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.76M

0% 3M change

49.65% 12M change

Total Value Held $30.7 Million

TAKEDA PHARMACEUTICAL CO LTD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 26 2021	SELL Open market or private sale	$453,291 $36.68 p/Share	12,358 Reduced 1.25%	977,238 Common Stock
May 25 2021	SELL Open market or private sale	$398,252 $36.38 p/Share	10,947 Reduced 1.09%	989,596 Common Stock
May 24 2021	SELL Open market or private sale	$379,689 $35.84 p/Share	10,594 Reduced 1.05%	1,000,543 Common Stock
May 21 2021	SELL Open market or private sale	$416,300 $35.74 p/Share	11,648 Reduced 1.14%	1,011,137 Common Stock
May 20 2021	SELL Open market or private sale	$249,140 $35.1 p/Share	7,098 Reduced 0.69%	1,022,785 Common Stock
May 14 2021	SELL Open market or private sale	$3,500 $35.0 p/Share	100 Reduced 0.01%	1,029,883 Common Stock
May 13 2021	SELL Open market or private sale	$3,533 $35.33 p/Share	100 Reduced 0.01%	1,029,983 Common Stock
May 12 2021	SELL Open market or private sale	$420,756 $35.73 p/Share	11,776 Reduced 1.13%	1,030,083 Common Stock
May 07 2021	SELL Open market or private sale	$35,415 $35.03 p/Share	1,011 Reduced 0.1%	1,041,859 Common Stock
May 06 2021	SELL Open market or private sale	$7,072 $35.01 p/Share	202 Reduced 0.02%	1,042,870 Common Stock
May 05 2021	SELL Open market or private sale	$243,731 $35.14 p/Share	6,936 Reduced 0.66%	1,043,072 Common Stock
May 04 2021	SELL Open market or private sale	$714,965 $36.93 p/Share	19,360 Reduced 1.81%	1,050,008 Common Stock
May 03 2021	SELL Open market or private sale	$561,430 $38.37 p/Share	14,632 Reduced 1.35%	1,069,368 Common Stock

Also insider at

THRX

Theseus Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

XLO

Xilio Therapeutics, Inc. Healthcare

> 10% Shareholder

DAWN

Day One Biopharmaceuticals, Inc. Healthcare

> 10% Shareholder

CALA

Calithera Biosciences, Inc. Healthcare

OVID

Ovid Therapeutics Inc. Healthcare

> 10% Shareholder

HLVX

HilleVax, Inc. Healthcare

> 10% Shareholder

TPC